Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Mental health, stigma, and neglected tropical diseases: A review and systematic mapping of the evidence

Koschorke M, Al-Haboubi YH, Tseng P, et al. Frontiers in Tropical Diseases. 2022;
Download PDF
Publication

Safety in administering medicines for neglected tropical diseases

World Health Organization . World Health Organization. 2021;
Download PDF
Publication

Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030

World Health Organization . 2021;
Download PDF
Publication

Infolep monthly e-newsletter on leprosy and related subjects

2020;
Publication

The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs.

Mendoza-Aguilar M, Almaguer-Villagrán L, Jiménez-Arellanes A, et al. Springer-Verlag Tokyo. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2012; 18 (5) : 652-61.
Publication

Assessment of knowledge and attitude toward leprosy among undergraduate medical students in north Kerala

Navya VS, Rajiv SV, George M, et al. Scientific Scholar. Journal of Skin and Sexually Transmitted Diseases. 2025;
Download PDF
Publication

Non-leprosy related dapsone hypersensitivity syndrome: A case report and literature review

Zhu H, Jiang S, Song G. Ovid Technologies (Wolters Kluwer Health). Medicine. 2025;
Download PDF
Publication

Knowledge and Skills of Leprosy Among Healthcare Workers and Its Associated Factors in Primary Healthcare

Zafirah TN, Ahmad Zaki R, Lim SH, et al. SAGE Publications. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2025;
Download PDF
Publication

Erythema Nodosum Leprosum in a Patient with Borderline Lepromatous Leprosy: A Case Report

Chiriboga G, Guo Q, Zuberi E, et al. MDPI AG. Infectious Disease Reports. 2025; 17 (4) : 83.
Download PDF
Publication

Disparities in leprosy relapse from 2001 to 2022 in Brazil

Barbosa-Lima R, Vivian GF, Gomes BGDN, et al. Instituto para o Desenvolvimento da Educacao. Journal of Health & Biological Sciences. 2025; 13 (1) : 1-7.
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD